February 04, 2026 - In concert with Trump Administration prioritization of AI development and investment in the United States, the Federal Trade Commission ("FTC" or the "Commission") has set out a ...

The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...

FTC Chairman Andrew Ferguson warned 42 law firms of anticompetitive practices involving their participation with Diversity Lab's Mansfield certification. The Am Law 100 firms contacted included some ...

Sens. Elizabeth Warren, Ron Wyden and Richard Blumenthal called on federal agencies to scrutinize AI deals from Nvidia, Meta and Google for potential antitrust violations, in a letter shared with CNBC ...

NewsGuard, a company that rates the reliability of online news outlets, is suing President Donald Trump’s Federal Trade Commission, alleging the agency has tried to drive it out of business because it ...

Express Scripts to change practices tied to high costs FTC to enforce 10-year settlement Deal requires company to work with local pharmacies Sign up here. "Our ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

The letters are a follow up to Ferguson’s 2025 directive to FTC staff identifying “collusion or unlawful coordination on DEI metrics” as a potentially unlawful practice that could diminish labor ...

Cigna Corp's Express Scripts has settled the U.S. Federal Trade Commission's claims its insulin pricing practices violated antitrust and consumer protection laws, and agreed to changes aimed at ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...